Category:
Anti-tumor Preparations
Standard:
N;
Bortezomib for Injection is is an anti-cancer drug and the first therapeutic proteasome inhibitor to be used in humans. It is used for the treatment of relapsed multiple myeloma and mantle cell lymphoma.
Bortezomib for Injection is a sterile, lyophilized pharmaceutical formulation of a proteasome inhibitor. Manufactured via aseptic filling and freeze-drying processes to ensure high purity and stability.